Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Keeping Injectable Spend in Check with Smarter Utilization Review
When injectables become common, inconsistency becomes costly.
Workers' Comp
Article
Field Case Management for Surgical Claims: Keep Plans Clear and Moving
The moment surgery is discussed, claims can get complex, fast. More providers. More appointments.
Workers' Comp
Podcast
Boosting Comp Outcomes Through Case Management-Physical Therapy Collaboration
Workers' Comp
News Release
Enlyte Announces Customer and Market Operations Leadership Transition
P&C veteran Keith Higdon assumes Enlyte CMO president position as Nina Smith transitions to vice chairman role, maintaining leadership con
Workers' Comp
Article
A Checklist of 8 Support Team Qualities to Look for When Choosing a Casualty Solutions Software Vendor
When you evaluate a software solution to support your casualty claims, you naturally focus on product features and pricing but leave a blind spot t
Risk & Insurance
Article